EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

YTHDC1‐dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple‐negative breast cancer

Xi Shen iD, Jianxin Zhong iD, Pan Yu, Feng Liu iD, Haoran Peng iD, Nianyong Chen iD

Cancer Science · 2024

DOI: 10.1111/cas.16137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Xi Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. Hauptthemen laut MEDLINE: Cell Proliferation, Disease Progression, Forkhead Box Protein M1, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple‐negative breast cancer (TNBC) exhibits heightened aggressiveness compared with other breast cancer (BC) subtypes, with earlier relapse, a higher risk of distant metastasis, and a worse prognosis. Transcription factors play a pivotal role in various cancers. Here, we found that factor forkhead box M1 (FOXM1) expression was significantly higher in TNBC than in other BC subtypes and normal tissues. Combining the findings of Gene Ontology (GO) enrichment analysis and a series of experiments, we found that knockdown of the FOXM1 gene attenuated the ability of TNBC cells to proliferate and metastasize both in vivo and in vitro. In addition, Spearman's test showed that FOXM1 significantly correlated with glycolysis‐related genes, especially centromere protein A (CENPA) in datasets (GSE76250, GSE76124, GSE206912, and GSE103091). The effect of silencing FOXM1 on the inhibition of CENPA expression, TNBC proliferation, migration, and glycolysis could be recovered by overexpression of CENPA. According to MeRIP, the level of m6A modification on FOMX1 decreased in cells treated with cycloleucine (a m6A inhibitor) compared with that in the control group. The increase in FOXM1 expression caused by YTHDC1 overexpression could be reversed by the m6A inhibitor, which indicated that YTHDC1 enhanced FOXM1 expression depending on m6A modification. Therefore, we concluded that the YTHDC1‐m6A modification/FOXM1/CENPA axis plays an important role in TNBC progression and glycolysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell ProliferationDisease ProgressionForkhead Box Protein M1Gene Expression Regulation, NeoplasticGlycolysisTriple Negative Breast NeoplasmsAnimalsFemaleHumansMiceAdenosineCell Line, TumorCell MovementChromosomal Proteins, Non-HistoneMice, NudeRNA Splicing FactorsCentromere Protein ANerve Tissue Proteins

Stichwörter der Autor:innen

CENPAFOXM1 transcription factorTNBCYTHDC1‐dependent m6A modificationglycolysis

Substanzen

AdenosineChromosomal Proteins, Non-HistoneForkhead Box Protein M1RNA Splicing FactorsFOXM1 protein, humanN-methyladenosineCENPA protein, humanCentromere Protein AYTHDC1 protein, humanNerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Oncology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
  • Department of Health Management, The Second Hospital Affiliated to Chongqing Medical University, Chongqing, China.
  • Department of Thyroid and Breast Surgery, Wuhan Fourth Hospital, Wuhan, China.
  • Department of Stomatology, Shenzhen Hospital, University of Chinese Academy of Sciences, Shenzhen, China.
  • Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Xi Shen, Jianxin Zhong, Feng Liu, Haoran Peng, Nianyong Chen

Zitieren

APA

Shen, X., Zhong, J., Yu, P., Liu, F., Peng, H., & Chen, N. (2024). YTHDC1‐dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple‐negative breast cancer. Cancer Science. https://doi.org/10.1111/cas.16137

Vancouver

Shen X, Zhong J, Yu P, Liu F, Peng H, Chen N. YTHDC1‐dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple‐negative breast cancer. Cancer Science. 2024. doi:10.1111/cas.16137

BibTeX
@article{Shen2024,
  author = {Shen, Xi and Zhong, Jianxin and Yu, Pan and Liu, Feng and Peng, Haoran and Chen, Nianyong},
  title = {YTHDC1‐dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple‐negative breast cancer},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16137}
}
Kostenlos starten →